Avenue Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ATXI Nasdaq 2834 http://www.avenuetx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avenue Therapeutics Inc

Abeona Therapeutics Announces Strategy Update and 2021 Financial Results - Mar 31st, 2022 11:30 am
FDA's AdComm Says Avenue Therapeutics Submitted Insufficient Data On IV Tramadol - Feb 16th, 2022 1:20 pm
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol - Feb 16th, 2022 3:00 am
Avenue Therapeutics Stock Trading Halted Today - Feb 15th, 2022 12:05 pm
Aegis Capital Corp. Acted as Sole Bookrunner on a $2 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI) - Dec 15th, 2021 7:15 pm
Avenue Therapeutics Announces Closing of Public Offering of Common Stock - Dec 15th, 2021 5:00 pm
Avenue Therapeutics Prices $2.0 Million Underwritten Public Offering of Common Stock - Dec 13th, 2021 1:00 am
Avenue Therapeutics Announces FDA Advisory Committee Meeting to Review IV Tramadol NDA Tentatively Scheduled for February 15, 2022 - Nov 29th, 2021 1:00 pm
Avenue Therapeutics Announces Exercise and Closing of Underwriter’s Over-Allotment Option - Nov 17th, 2021 2:30 pm
Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI) - Nov 12th, 2021 3:40 pm
Avenue Therapeutics Prices $2.6 Million Underwritten Public Offering of Common Stock - Nov 10th, 2021 2:30 am
Avenue Therapeutics Receives Interim Response to its Formal Dispute Resolution Request from U.S. Food and Drug Administration Office of New Drugs - Oct 25th, 2021 11:00 am
Amneal (AMRX) Parkinson's Candidate Successful in Pivotal Study - Aug 26th, 2021 3:04 pm
Monday’s Pre-Market: Here’s What You Need to Know Before the Market Opens - Jun 21st, 2021 12:04 pm
CORRECTED-U.S. FDA declines to approve Avenue's painkiller again, shares drop - Jun 14th, 2021 11:44 am
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol - Jun 14th, 2021 11:00 am